Canton Hathaway’s BioLife Solutions BLFS Stock Holding History

Canton Hathaway’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,460	Closed	-$66K	–	226
2018 Q4	$66K	Buy	+5,460	New	+$65.2K	0.04%	99

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

SCM

Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Canton Hathaway's BLFS Position: Q1 2019 in Review

Canton Hathaway sold out of BioLife Solutions (BLFS) in Q1 2019, closing a stake of 5,460 shares — an estimated $66K sold.

Canton Hathaway first reported a position in BLFS in Q4 2018 and held it in 1 quarter. The position peaked at $66K in Q4 2018. 66 funds tracked by Wall St. Rank hold BLFS as of Q1 2019.

Canton Hathaway reported no remaining BioLife Solutions position as of Q1 2019 after selling out during the quarter.
Canton Hathaway sold 5,460 BioLife Solutions shares in Q1 2019, an estimated $66K.
Canton Hathaway first reported a position in BioLife Solutions in Q4 2018 and held it in 1 quarter.
Canton Hathaway's BioLife Solutions position peaked at $66K in Q4 2018.
66 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2019.

Based on Canton Hathaway's 13F filing for Q1 2019, filed 10 Apr 2019.